Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of CYP3A5 polymorphisms on intra-patient variability of tacrolimus pharmacokinetics in kidney transplant recipients
TCTR20180619003Enrolling by invitation
- Sponsor
- Chulalongkorn University
- Start
- Jun 2018
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tacrolimus in Kidney allograft status (RTx), sponsored by Chulalongkorn University. Primary endpoint: Intra-patient variability of tacrolimus pharmacokinetics. Started Jun 2018; status: enrolling by invitation.
02
Drugs
tacrolimus
03
Conditions
Kidney allograft status (RTx)
Beyond the preview
Go deeper on TCTR20180619003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180619003.